Quest Research Institute

Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054

Laura Fanning, Serena Hung, Aaron Ellenbogen et al. · Movement Disorders · 2019 · 194 citations · Full text

Life Sciences, Neurology, Pharmacology +17

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease

Robert A. Hauser, Aaron Ellenbogen, Leo Verhagen Metman et al. · Movement Disorders · 2011 · 102 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

A randomized trial of inhaled levodopa (CVT‐301) for motor fluctuations in Parkinson's disease

Peter A. LeWitt, Robert A. Hauser, Donald G. Grosset et al. · Movement Disorders · 2016 · 94 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

Ana Westenberger, Volha Skrahina, Tatiana Usnich et al. · Brain · 2024 · 89 citations · Full text

Life Sciences, Genetics, Neurology +15

Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients

Fabrizio Stocchi, Ann Hsu, Sarita Khanna et al. · Parkinsonism & Related Disorders · 2014 · 74 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15